Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Genetics
Volume 2015, Article ID 454526, 4 pages
http://dx.doi.org/10.1155/2015/454526
Case Report

Whole Exome Sequencing Reveals Compound Heterozygosity for Ethnically Distinct PEX7 Mutations Responsible for Rhizomelic Chondrodysplasia Punctata, Type 1

1Centre for Brain Research and School of Biological Sciences, The University of Auckland, Auckland 1010, New Zealand
2Adult and Paediatric National Metabolic Service, Auckland City Hospital, Auckland 1142, New Zealand
3Genetic Health Service New Zealand, Auckland City Hospital, Auckland 1142, New Zealand
4Department of Radiology, Auckland City Hospital, Auckland 1142, New Zealand
5Department of Biochemical Genetics, SA Pathology, North Adelaide, SA 5006, Australia
6Department of Diagnostic Genomics, PathWest, Nedlands, WA 6009, Australia
7Department of Genome Analysis, Academic Medical Centre, 1105 Amsterdam, Netherlands
8Department of Neurology, Auckland City Hospital, Auckland 1142, New Zealand
9Developmental Paediatric Service, Starship Children’s Health, Auckland 1142, New Zealand
10Diagnostic Genetics, LabPLUS, Auckland City Hospital, Auckland 1142, New Zealand
11Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand

Received 6 July 2015; Accepted 5 October 2015

Academic Editor: Mohnish Suri

Copyright © 2015 Jessie C. Jacobsen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. E. Braverman, A. B. Moser, and S. J. Steinberg, “Rhizomelic chondrodysplasia punctata type 1,” in GeneReviews, R. A. Pagon, M. P. Adam, H. H. Ardinger et al., Eds., University of Washington, Seattle, Wash, USA, 2001. View at Google Scholar
  2. A. M. Motley, P. Brites, L. Gerez et al., “Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1,” The American Journal of Human Genetics, vol. 70, no. 3, pp. 612–624, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Noguchi, M. Honsho, Y. Abe et al., “Mild reduction of plasmalogens causes rhizomelic chondrodysplasia punctata: functional characterization of a novel mutation,” Journal of Human Genetics, vol. 59, no. 7, pp. 387–392, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Stoll, B. Dott, M.-P. Roth, and Y. Alembik, “Birth prevalence rates of skeletal dysplasias,” Clinical Genetics, vol. 35, no. 2, pp. 88–92, 1989. View at Google Scholar · View at Scopus
  5. R. J. Wanders, “Metabolic and molecular basis of peroxisomal disorders: a review,” American Journal of Medical Genetics Part A, vol. 126, no. 4, pp. 355–375, 2004. View at Publisher · View at Google Scholar
  6. V. Apgar, “A proposal for a new method of evaluation of the newborn infant,” Current Researches in Anesthesia & Analgesia, vol. 32, no. 4, pp. 260–267, 1953. View at Google Scholar · View at Scopus
  7. P. Brites, A. Motley, E. Hogenhout et al., “Molecular basis of rhizomelic chondrodysplasia punctata type I: high frequency of the Leu-292 Stop mutation in 38 patients,” Journal of Inherited Metabolic Disease, vol. 21, no. 3, pp. 306–308, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Shimozawa, Y. Suzuki, Z. Zhang et al., “A novel nonsense mutation of the PEX7 gene in a patient with rhizomelic chondrodysplasia punctata,” Journal of Human Genetics, vol. 44, no. 2, pp. 123–125, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Suzuki, N. Shimozawa, K. Izai et al., “Peroxisomal 3-ketoacyl-CoA thiolase is partially processed in fibroblasts from patients with rhizomelic chondrodysplasia punctata,” Journal of Inherited Metabolic Disease, vol. 16, no. 5, pp. 868–871, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. Exome Aggregation Consortium (ExAC), Cambridge, Mass, USA, May 2015, http://exac.broadinstitute.org.
  11. A. M. Bams-Mengerink, J. H. T. M. Koelman, H. Waterham, P. G. Barth, and B. T. Poll-The, “The neurology of rhizomelic chondrodysplasia punctata,” Orphanet Journal of Rare Diseases, vol. 8, no. 1, article 174, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Braverman, C. Argyriou, and A. Moser, “Human disorders of peroxisome biogenesis: zellweger spectrum and rhizomelic chondrodysplasia punctata,” in Molecular Machines Involved in Peroxisome Biogenesis and Maintenance, C. Brocard and A. Hartig, Eds., pp. 63–90, Springer, Vienna, Austria, 2014. View at Publisher · View at Google Scholar
  13. S. Ferdinandusse, S. Barker, K. Lachlan et al., “Adult peroxisomal acyl-coenzyme A oxidase deficiency with cerebellar and brainstem atrophy,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 81, no. 3, pp. 310–312, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. P. G. Barth, R. J. A. Wanders, R. B. H. Schutgens, and C. R. Staalman, “Variant rhizomelic chondrodysplasia punctata (RCDP) with normal plasma phytanic acid: clinico-biochemical delineation of a subtype and complementation studies,” American Journal of Medical Genetics, vol. 62, no. 2, pp. 164–168, 1996. View at Google Scholar · View at Scopus
  15. S. E. Heron, H. Khosravani, D. Varela et al., “Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants,” Annals of Neurology, vol. 62, no. 6, pp. 560–568, 2007. View at Publisher · View at Google Scholar · View at Scopus